___

• Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, et al. Curcumin bioavailability, a problem in humans: lessons from clinical trials. Expert Opin Drug Metab Toxicol. 2019;15(9):705-33.
• Castaño PR, Parween S, Pandey AV. Bioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathway. Int J Mol Sci. 2019;20(18):460.
• Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutr. 2015; 34:1101-8.
• Adiwidjaja J, McLachlan AJ, Boddy AV. Curcumin as clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol. 2017;13(9):953-72.
• Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Letters. 2007;255:170–81.
• Greenlee H, Melissa J, DuPont-Reyes MPH, MPhil Lynda G, Balneaves RN, Linda E, et al. Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment. CA Cancer J Clin. 2017;67:194–232.
• Witt CA, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnston P, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017; 1:2017(52).
• National Cancer Institute. Office of Complemantary and Alternative Medicine: Research Resources. Available at: https://cam.cancer.gov/international_affairs/research_ resources.htm#h04 Accessed December 26, 2019.
• National Cancer Institute. Search Link. Available at: https://www.cancer.gov/search/results December 26, 2019.